Pyoderma gangrenosum in inflammatory bowel disease: The experience at Mater Health Services' Adult Hospital 1998-2009

Journal of Crohn's and Colitis

Volumn 5, Issue 2, 2011, Pages 148-151

  Polcz, Margit ^a   Gu, Jennie ^a   Florin, Timothy ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b MATER HOSPITAL   (Australia)

Author keywords

Crohn's disease; Extraintestinal manifestations; Inflammatory bowel disease; Pyoderma gangrenosum; Ulcerative colitis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; STEROID; TACROLIMUS;

ADULT; ARTICLE; AUSTRALIA; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENTERITIS; ERYTHEMA NODOSUM; FEMALE; HOSPITAL; HUMAN; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PYODERMA GANGRENOSUM;

6-MERCAPTOPURINE; ADULT; ANTI-INFLAMMATORY AGENTS; COLITIS, ULCERATIVE; CROHN DISEASE; CYCLOSPORINS; FEMALE; HUMANS; HYDROCORTISONE; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREVALENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PYODERMA GANGRENOSUM; SEX FACTORS; WOUNDS AND INJURIES;

EID: 79953082236     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2010.10.006     Document Type: Article

References (20)

1. Vadillo M., Jucgla A., Podzamczer D., Rufi G., Domingo A. Pyoderma gangrenosum with liver, spleen and bone involvement in a patient with chronic myelomonocytic leukemia. Br J Dermatol 1999, 141:541-543.
2. Brunsting L.A., Goeckerman W.H., O'Leary P.A. Pyoderma (ecthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol Syph 1930, 22:655-680.
3. Von Den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 1997, 137:1000-1005.
4. Powell F.C., Su W.P., Perry H.O. Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996, 34:395-409.
5. Powell F.C., Schroeter A.L., Su W.P., Perry H.O. Pyoderma gangrenosum: a review of 86 patients. Q J Med 1985, 55:173-186.
6. Finkel S.I., Janowitz H.D. Trauma and the pyoderma gangrenosum of inflammatory bowel disease. Gut 1981, 22:410-412.
7. Wollina U. Pyoderma gangrenosum: a review. Orphanet J Rare Dis 2007, 15:1-8.
8. Gellert A., Green E.S., Beck E.R., Ridley C.M. Erythema nodosum progressing to pyoderma gangrenosum as a complication of Crohn's disease. Postgrad Med J 1983, 59:791-793.
9. Wallach D., Vignon-Pennamen M.D. From acute febrile neutrophilic dermatosis to neutrophilic disease: forty years of clinical research. J Am Acad Dermatol 2006, 55:1066-1071.
10. Brooklyn T., Dunnill M.G., Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ 2006, 22:181-184.
11. Farhi D., Cosnes J., Zizi N., Chosidow O., Seksik P., Beaugerie L., et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease: a cohort study of 2402 patients. Medicine 2008, 87:281-293.
12. Charles C.A., Bialy T.L., Falabella A.F., Eaglstein W.H., Kerdel F.A., Kirsner R.S. Poor prognosis of arthritis associated pyoderma gangrenosum. Arch Dermatol 2004, 140:861-864.
13. Vidal D., Puig L., Gilaberte M., Alomar A. Review of 26 cases of classical pyoderma gangrenosum: clinical and therapeutic features. J Dermatolog Treat 2004, 15:146-152.
14. Shaya S., Kindzelskii A.L., Minor J., Moore E.C., Todd R.F., Petty H.R. Aberrant integrin (CR4; alpha(x)beta2;CD11c/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosum. J Invest Dermatol 1998, 111:154-158.
15. Adachi Y., Kindzelskii A.L., Cookingham G., Shaya S., Moore E.C., Todd R.F., et al. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol 1998, 111:259-268.
16. Mann E.R., Al-Hassi H.O., Clark S., McCarthy N.E., Cochrane S.A., Hart A., et al. M1677 imprinting of lymphocyte homing to skin and gut by human tissue DC. Gastroenterology 2009, 136:A-408.
17. Mora J.R. Homing, imprinting and immunomodulation in the gut: role of dendritic cels and retinoids. Inflamm Bowel Dis 2008, 14:275-289.
18. Andre M.F., Aumaitre O., Grateau G., Chamaillard M., Costedoat-Chalumeau N., Cardoso M.C., et al. Longest form of CCTG microsatellite repeat in the promoter of the CD2BP1/PSTPIP1 gene is associated with aseptic abscesses and with crohn disease in french patients. Dig Dis Sci 2010, 55:1681-1688.
19. Matis W.L., Ellis C.N., Griffiths C.E., Lazarus G.S. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 1992, 128:1060-1064.
20. Brooklyn T.N., Dunnil M.G., Shetty A., Bowden J.J., Williams J.D., Griffiths C.E., et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006, 55:505-509.